Renal Cancer - Results from #5440

3D printed renal cancer models derived from MRI data: application in pre-surgical planning January 9, 2017

Mixed Results for Sunitinib in Renal Cancer January 9, 2017

Biological toxicities as surrogate markers of efficacy in patients treated with mTOR inhibitors for metastatic renal cell carcinoma January 9, 2017

Oncology Gold Standard™ practical consensus recommendations 2016 for treatment of advanced clear cell renal cell carcinoma. January 9, 2017

How clinical practice is changing the rules: the sunitinib 2/1 schedule in metastatic renal cell carcinoma January 9, 2017

Pretreatment Lymphocyte to Monocyte Ratio is an Independent Prognostic Factor in Metastatic Clear Cell Renal Cell Carcinoma January 9, 2017

Prognostic Value of Plasma and Urine Glycosaminoglycan Scores in Clear Cell Renal Cell Carcinoma December 29, 2016

Targeting HIF2 in Clear Cell Renal Cell Carcinoma December 29, 2016

Laparoscopic Nephrectomy: Initial Case Report December 29, 2016

Effective downsizing but enhanced intratumoral heterogeneity following neoadjuvant sorafenib in patients with non-metastatic renal cell carcinoma December 29, 2016

Mutations in the Mitochondrial ND1 Gene Are Associated with Postoperative Prognosis of Localized Renal Cell Carcinoma December 28, 2016

Surgical treatment of chronic multivascular mesenteric ischemia in a patient with antiphospholipid syndrome, abdominal aortic aneurism, and renal cancer: when planning overwhelms complexity December 28, 2016

A Systematic Review and Meta-analysis Comparing the Effectiveness and Adverse Effects of Different Systemic Treatments for Non-clear Cell Renal Cell Carcinoma December 28, 2016

K-Ras, H-Ras, N-Ras and B-Raf mutation and expression analysis in Wilms tumors: association with tumor growth December 27, 2016

Long-term benefit of sunitinib in patients with metastatic renal cell carcinoma in Latin America: retrospective analysis of patient clinical characteristics December 27, 2016

Influence of Tyrosine Kinase Inhibitors on Hypertension and Nephrotoxicity in Metastatic Renal Cell Cancer Patients December 27, 2016

Higher programmed cell death 1 ligand 1 (PD-L1) mRNA level in clear cell renal cell carcinomas is associated with a favorable outcome due to the active immune responses in tumor tissues December 23, 2016

Perivascular PDGFR-β is an independent marker for prognosis in renal cell carcinoma. December 23, 2016

A Novel PD-L1-targeting Antagonistic DNA Aptamer With Antitumor Effects December 22, 2016

Cancer incidence and survival trends by subtype using data from the Surveillance Epidemiology and End Results Program, 1992-2013 December 22, 2016

Page 273 of 458